Elixxer Ltd. (ELIXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0335
+0.0223 (199.11%)
At close: Jan 22, 2026
Elixxer Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.19M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CannaPharmaRX | 1.71M |
| Bespoke Extracts | 1.42M |
| SOHM, Inc. | 1.30M |
| Trees | 14.50M |
| Bio Essence | 565.67K |
| Panacea Life Sciences Holdings | 2.76M |
| Medical Marijuana | 58.98M |
| Redwood Scientific Technologies | 259.71K |
Elixxer News
- 5 weeks ago - Elixxer Provides Update on Secured and Unsecured Loans - Newsfile Corp
- 7 weeks ago - Elixxer Announces Completion of Debt Settlement - Newsfile Corp
- 2 months ago - Elixxer Announces Results of Annual and Special Meeting of Shareholders - Newsfile Corp
- 4 months ago - Elixxer Ltd. Provides Update and Corrective Statements on Proposed Debt Settlement and Upcoming Shareholder Meeting - Newsfile Corp
- 6 months ago - Elixxer Ltd. Announces Debt Settlement - Newsfile Corp
- 6 months ago - Elixxer Ltd. Announces Proposed Shares for Debt Settlements - Newsfile Corp
- 8 months ago - Elixxer Provides Corporate Update - Newsfile Corp
- 9 months ago - Elixxer Announces Bridge Loan - Newsfile Corp